MICS Trademark
Trademark Overview
On Thursday, April 25, 2024, a trademark application was filed for MICS with the United States Patent and Trademark Office. The USPTO has given the MICS trademark a serial number of 98519386. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, December 12, 2024. This trademark is owned by Spiral Therapeutics, Inc.. The MICS trademark is filed in the Medical Instrument Products category with the following description:
Devices that facilitate the delivery of medication, namely, transdermal drug delivery patches sold without medication; Surgical implants for the ear comprising artificial material, and not comprising microphone or sound-enhancing features; Medical devices, apparatus and applicators thereof, namely, shunts, stents, cannulae, medical, surgical and orthopaedic implants for use in the inner ear made of artificial materials, not comprising microphone or sound-enhancing features; Surgical cutting instruments for use in surgery of the inner ear; Medical devices, namely, shunt and stent applicators; Hearing screening instruments in the nature of medical testing devices for measuring hearing loss in patients, namely, audiometers
General Information
| Serial Number | 98519386 |
| Word Mark | MICS |
| Filing Date | Thursday, April 25, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, December 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
| Goods and Services | Devices that facilitate the delivery of medication, namely, transdermal drug delivery patches sold without medication; Surgical implants for the ear comprising artificial material, and not comprising microphone or sound-enhancing features; Medical devices, apparatus and applicators thereof, namely, shunts, stents, cannulae, medical, surgical and orthopaedic implants for use in the inner ear made of artificial materials, not comprising microphone or sound-enhancing features; Surgical cutting instruments for use in surgery of the inner ear; Medical devices, namely, shunt and stent applicators; Hearing screening instruments in the nature of medical testing devices for measuring hearing loss in patients, namely, audiometers |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Friday, May 10, 2024 |
| First Use In Commerce Date | Friday, May 10, 2024 |
Trademark Owner History
| Party Name | Spiral Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94080 |
Trademark Events
| Event Date | Event Description |
| Thursday, April 25, 2024 | NEW APPLICATION ENTERED |
| Thursday, April 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 15, 2024 | USE AMENDMENT FILED |
| Wednesday, May 15, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Wednesday, May 15, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Monday, September 23, 2024 | ASSIGNED TO LIE |
| Monday, November 11, 2024 | ASSIGNED TO EXAMINER |
| Monday, September 23, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Tuesday, November 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 6, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, December 9, 2024 | USE AMENDMENT ACCEPTED |
| Tuesday, November 12, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 12, 2024 | NON-FINAL ACTION WRITTEN |
